Literature DB >> 19428572

A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.

Jun Xu1, Matthew Kelly, Warren Denning, Zdenek Hel.   

Abstract

HIV-1 Gag protein represents a promising target of cellular immunity-based vaccines due to its immunogenicity and high conservation among diverse viral subtypes. Development of novel and effective Gag-targeted vaccine candidates inducing CD8(+) and CD4(+) T cell responses requires large scale pre-clinical testing in a small animal model. In this report, the MHC class I and II-restricted epitopes in the simian immunodeficiency virus (SIV) Gag protein recognized in C57Bl/6 and Balb/c mice were determined and characterized. In addition, using the newly defined epitopes, the relationship is described between the amount of plasmid DNA, volume of inoculate, and the extent of ensuing immune responses following intramuscular DNA immunization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428572      PMCID: PMC2913547          DOI: 10.1016/j.jviromet.2009.01.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  21 in total

1.  Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes.

Authors:  Zdenek Hel; Wen-Po Tsai; Elzbieta Tryniszewska; Janos Nacsa; Phillip D Markham; Mark G Lewis; George N Pavlakis; Barbara K Felber; Jim Tartaglia; Genoveffa Franchini
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 2.  DNA vaccines: recent developments and future possibilities.

Authors:  Margaret A Liu; Britta Wahren; Gunilla B Karlsson Hedestam
Journal:  Hum Gene Ther       Date:  2006-11       Impact factor: 5.695

3.  Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.

Authors:  T Matano; R Shibata; C Siemon; M Connors; H C Lane; M A Martin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.

Authors:  Norman L Letvin; John R Mascola; Yue Sun; Darci A Gorgone; Adam P Buzby; Ling Xu; Zhi-Yong Yang; Bimal Chakrabarti; Srinivas S Rao; Jörn E Schmitz; David C Montefiori; Brianne R Barker; Fred L Bookstein; Gary J Nabel
Journal:  Science       Date:  2006-06-09       Impact factor: 47.728

5.  HIV infection: first battle decides the war.

Authors:  Zdenek Hel; Jerry R McGhee; Jiri Mestecky
Journal:  Trends Immunol       Date:  2006-05-06       Impact factor: 16.687

6.  Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.

Authors:  Jinyan Liu; Bonnie A Ewald; Diana M Lynch; Anjali Nanda; Shawn M Sumida; Dan H Barouch
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.

Authors:  J T Qiu; R Song; M Dettenhofer; C Tian; T August; B K Felber; G N Pavlakis; X F Yu
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

Authors:  David I Watkins; Dennis R Burton; Esper G Kallas; John P Moore; Wayne C Koff
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

Review 9.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  1 in total

1.  A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination.

Authors:  Catherine M Crosby; Eric A Weaver; Reeti Khare; Michael A Barry
Journal:  Virol Rep       Date:  2015-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.